Cargando…

A biomarker basing on radiomics for the prediction of overall survival in non–small cell lung cancer patients

BACKGROUND: This study aimed at predicting the survival status on non-small cell lung cancer patients with the phenotypic radiomics features obtained from the CT images. METHODS: A total of 186 patients’ CT images were used for feature extraction via Pyradiomics. The minority group was balanced via...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Bo, Zhao, Wei, Pi, Jiang-Yuan, Han, Dan, Jiang, Yuan-Ming, Zhang, Zhen-Guang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180390/
https://www.ncbi.nlm.nih.gov/pubmed/30305102
http://dx.doi.org/10.1186/s12931-018-0887-8
_version_ 1783362188866486272
author He, Bo
Zhao, Wei
Pi, Jiang-Yuan
Han, Dan
Jiang, Yuan-Ming
Zhang, Zhen-Guang
Zhao, Wei
author_facet He, Bo
Zhao, Wei
Pi, Jiang-Yuan
Han, Dan
Jiang, Yuan-Ming
Zhang, Zhen-Guang
Zhao, Wei
author_sort He, Bo
collection PubMed
description BACKGROUND: This study aimed at predicting the survival status on non-small cell lung cancer patients with the phenotypic radiomics features obtained from the CT images. METHODS: A total of 186 patients’ CT images were used for feature extraction via Pyradiomics. The minority group was balanced via SMOTE method. The final dataset was randomized into training set (n = 223) and validation set (n = 75) with the ratio of 3:1. Multiple random forest models were trained applying hyperparameters grid search with 10-fold cross-validation using precision or recall as evaluation standard. Then a decision threshold was searched on the selected model. The final model was evaluated through ROC curve and prediction accuracy. RESULTS: From those segmented images of 186 patients, 1218 features were obtained via feature extraction. The preferred model was selected with recall as evaluation standard and the optimal decision threshold was set 0.56. The model had a prediction accuracy of 89.33% and the AUC score was 0.9296. CONCLUSION: A hyperparameters tuning random forest classifier had greater performance in predicting the survival status of non-small cell lung cancer patients, which could be taken for an automated classifier promising to stratify patients. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12931-018-0887-8) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6180390
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-61803902018-10-18 A biomarker basing on radiomics for the prediction of overall survival in non–small cell lung cancer patients He, Bo Zhao, Wei Pi, Jiang-Yuan Han, Dan Jiang, Yuan-Ming Zhang, Zhen-Guang Zhao, Wei Respir Res Research BACKGROUND: This study aimed at predicting the survival status on non-small cell lung cancer patients with the phenotypic radiomics features obtained from the CT images. METHODS: A total of 186 patients’ CT images were used for feature extraction via Pyradiomics. The minority group was balanced via SMOTE method. The final dataset was randomized into training set (n = 223) and validation set (n = 75) with the ratio of 3:1. Multiple random forest models were trained applying hyperparameters grid search with 10-fold cross-validation using precision or recall as evaluation standard. Then a decision threshold was searched on the selected model. The final model was evaluated through ROC curve and prediction accuracy. RESULTS: From those segmented images of 186 patients, 1218 features were obtained via feature extraction. The preferred model was selected with recall as evaluation standard and the optimal decision threshold was set 0.56. The model had a prediction accuracy of 89.33% and the AUC score was 0.9296. CONCLUSION: A hyperparameters tuning random forest classifier had greater performance in predicting the survival status of non-small cell lung cancer patients, which could be taken for an automated classifier promising to stratify patients. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12931-018-0887-8) contains supplementary material, which is available to authorized users. BioMed Central 2018-10-10 2018 /pmc/articles/PMC6180390/ /pubmed/30305102 http://dx.doi.org/10.1186/s12931-018-0887-8 Text en © The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
He, Bo
Zhao, Wei
Pi, Jiang-Yuan
Han, Dan
Jiang, Yuan-Ming
Zhang, Zhen-Guang
Zhao, Wei
A biomarker basing on radiomics for the prediction of overall survival in non–small cell lung cancer patients
title A biomarker basing on radiomics for the prediction of overall survival in non–small cell lung cancer patients
title_full A biomarker basing on radiomics for the prediction of overall survival in non–small cell lung cancer patients
title_fullStr A biomarker basing on radiomics for the prediction of overall survival in non–small cell lung cancer patients
title_full_unstemmed A biomarker basing on radiomics for the prediction of overall survival in non–small cell lung cancer patients
title_short A biomarker basing on radiomics for the prediction of overall survival in non–small cell lung cancer patients
title_sort biomarker basing on radiomics for the prediction of overall survival in non–small cell lung cancer patients
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180390/
https://www.ncbi.nlm.nih.gov/pubmed/30305102
http://dx.doi.org/10.1186/s12931-018-0887-8
work_keys_str_mv AT hebo abiomarkerbasingonradiomicsforthepredictionofoverallsurvivalinnonsmallcelllungcancerpatients
AT zhaowei abiomarkerbasingonradiomicsforthepredictionofoverallsurvivalinnonsmallcelllungcancerpatients
AT pijiangyuan abiomarkerbasingonradiomicsforthepredictionofoverallsurvivalinnonsmallcelllungcancerpatients
AT handan abiomarkerbasingonradiomicsforthepredictionofoverallsurvivalinnonsmallcelllungcancerpatients
AT jiangyuanming abiomarkerbasingonradiomicsforthepredictionofoverallsurvivalinnonsmallcelllungcancerpatients
AT zhangzhenguang abiomarkerbasingonradiomicsforthepredictionofoverallsurvivalinnonsmallcelllungcancerpatients
AT zhaowei abiomarkerbasingonradiomicsforthepredictionofoverallsurvivalinnonsmallcelllungcancerpatients
AT hebo biomarkerbasingonradiomicsforthepredictionofoverallsurvivalinnonsmallcelllungcancerpatients
AT zhaowei biomarkerbasingonradiomicsforthepredictionofoverallsurvivalinnonsmallcelllungcancerpatients
AT pijiangyuan biomarkerbasingonradiomicsforthepredictionofoverallsurvivalinnonsmallcelllungcancerpatients
AT handan biomarkerbasingonradiomicsforthepredictionofoverallsurvivalinnonsmallcelllungcancerpatients
AT jiangyuanming biomarkerbasingonradiomicsforthepredictionofoverallsurvivalinnonsmallcelllungcancerpatients
AT zhangzhenguang biomarkerbasingonradiomicsforthepredictionofoverallsurvivalinnonsmallcelllungcancerpatients
AT zhaowei biomarkerbasingonradiomicsforthepredictionofoverallsurvivalinnonsmallcelllungcancerpatients